Prakash Jayakumar1, Joost T P Kortlever2, Laura E Brown3, David Ring2. 1. UK Harkness Fellowship in Health Care Policy and Practice Innovations, The Value Institute / Department of Surgery and Peri-operative Care, The University of Texas at Austin, Dell Medical School, Austin, TX, USA. 2. Department of Surgery and Peri-operative Care, The University of Texas at Austin, Dell Medical School, Austin, TX, USA. 3. Center for Health Communication, The University of Texas at Austin, Dell Medical School, Austin, TX, USA.
Abstract
BACKGROUND: Shortened versions of validated PRO measures of coping strategies e.g. PSEQ-2, may facilitate screening and monitoring of psychological conditions such as depression and anxiety. The primary research question in this study assesses the sensitivity and specificity of a PSEQ-2 score of less than 10 for important symptoms of depression (a PHQ-2 score greater than 2), anxiety (GAD-2 score greater than 2), any impactful prior episode of psychological trauma, and QuickDASH greater than 49. Secondarily we assess the associations between self-efficacy and other demographic and psychological factors on the magnitude of limitations and pain intensity. METHODS: We performed a retrospective PRO evaluation in 926 adult patients attending an upper extremity clinic between 1st January 2018 and 31st January 2019. Demographic factors were assessed using electronic medical records and PRO data using an online platform. Patients included 556 (60%) women, 370 (40%) men (mean 51 years ± 14 (range, 19-88), mostly (n=584, 63%) with safety net insurance. RESULTS: A PSEQ-2 scoring threshold of less than 10 was 81% sensitive for a PHQ-2 score of 3 or greater, 84% sensitive for a GAD-2 score of 3 or greater, 84% sensitive for one or more important psychological traumas, and 82% sensitive for a QuickDASH of 50 or greater. PSEQ-2 less than 10 was independently associated with greater upper extremity limitations (β=11 [6.3 to 17, 95% Confidence interval [C.I], P<0.001) and pain intensity (β=0.92 (0.31 to 1.5, 95% C.I) P=0.003) amongst other psychological and demographic factors. CONCLUSION: A PSEQ-2 score of less than 10 might, along with verbal and non-verbal signs of distress, be a useful way to introduce the use of more sensitive screening questionnaires about anxiety or depression, or open up the option of speaking directly to mental or social health professionals. Future studies are required to test this hypothesis.
BACKGROUND: Shortened versions of validated PRO measures of coping strategies e.g. PSEQ-2, may facilitate screening and monitoring of psychological conditions such as depression and anxiety. The primary research question in this study assesses the sensitivity and specificity of a PSEQ-2 score of less than 10 for important symptoms of depression (a PHQ-2 score greater than 2), anxiety (GAD-2 score greater than 2), any impactful prior episode of psychological trauma, and QuickDASH greater than 49. Secondarily we assess the associations between self-efficacy and other demographic and psychological factors on the magnitude of limitations and pain intensity. METHODS: We performed a retrospective PRO evaluation in 926 adult patients attending an upper extremity clinic between 1st January 2018 and 31st January 2019. Demographic factors were assessed using electronic medical records and PRO data using an online platform. Patients included 556 (60%) women, 370 (40%) men (mean 51 years ± 14 (range, 19-88), mostly (n=584, 63%) with safety net insurance. RESULTS: A PSEQ-2 scoring threshold of less than 10 was 81% sensitive for a PHQ-2 score of 3 or greater, 84% sensitive for a GAD-2 score of 3 or greater, 84% sensitive for one or more important psychological traumas, and 82% sensitive for a QuickDASH of 50 or greater. PSEQ-2 less than 10 was independently associated with greater upper extremity limitations (β=11 [6.3 to 17, 95% Confidence interval [C.I], P<0.001) and pain intensity (β=0.92 (0.31 to 1.5, 95% C.I) P=0.003) amongst other psychological and demographic factors. CONCLUSION: A PSEQ-2 score of less than 10 might, along with verbal and non-verbal signs of distress, be a useful way to introduce the use of more sensitive screening questionnaires about anxiety or depression, or open up the option of speaking directly to mental or social health professionals. Future studies are required to test this hypothesis.
Authors: Joost T P Kortlever; Stein J Janssen; Marijn M G van Berckel; David Ring; Ana Maria Vranceanu Journal: Clin Orthop Relat Res Date: 2015-11 Impact factor: 4.176
Authors: Shaan A Ahmed; Govind Shantharam; Adam E M Eltorai; Davis A Hartnett; Avi Goodman; Alan H Daniels Journal: Spine J Date: 2018-06-12 Impact factor: 4.166
Authors: Alessandro Chiarotto; Carla Vanti; Christine Cedraschi; Silvano Ferrari; Fernanda de Lima E Sà Resende; Raymond W Ostelo; Paolo Pillastrini Journal: J Pain Date: 2016-03-11 Impact factor: 5.820
Authors: Ana-Maria Vranceanu; Steven Safren; Meijuan Zhao; James Cowan; David Ring Journal: Clin Orthop Relat Res Date: 2008-07-18 Impact factor: 4.176
Authors: Jason M Guattery; Agnes Z Dardas; Michael Kelly; Aaron Chamberlain; Christopher McAndrew; Ryan P Calfee Journal: Clin Orthop Relat Res Date: 2018-04 Impact factor: 4.176